High-Fidelity Long-Read Sequencing Market Forecast Reveals Where Future Industry Value Will Be Created
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
High-Fidelity Long-Read Sequencing Market Growth From $1.88 Billion In 2026 To $4.22 Billion By 2030 At A CAGR Of 22.5%
The high-fidelity long-read sequencing market has experienced rapid expansion over the last few years. Projections indicate it will expand from $1.53 billion in 2025 to $1.88 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.2%. Historically, this growth has stemmed from breakthroughs in sequencing chemistry precision, initial uptake within genomics research facilities, the proliferation of extensive genome initiatives, a rising need for structural variant assessment, and enhancements in sequencing hardware capabilities.
The high-fidelity long-read sequencing market size is anticipated to undergo significant expansion in the coming years, with projections indicating a growth to $4.22 billion by 2030, reflecting a compound annual growth rate (CAGR) of 22.5%. This projected growth during the forecast period is primarily driven by factors such as the increasing implementation of precision medicine strategies, greater investments in genomics-focused drug discovery, an expansion in rare disease research, the rising clinical integration of long-read sequencing, and continuous improvements in sequencing cost efficiency. Key trends expected over the forecast period include the broader acceptance of long-read sequencing in clinical diagnostics, an escalating demand for highly accurate variant detection, the growing application of de novo genome assembly techniques, an expansion in epigenetic and transcriptomic analysis applications, and enhanced integration of sophisticated bioinformatics tools.
Download A Free Sample Report For Comprehensive Market Insights:
High-Fidelity Long-Read Sequencing Market Expansion Drivers: What Is Shaping Future Growth?
The increasing occurrence of rare diseases is anticipated to boost the growth of the HiFi long-read sequencing market in the future. Rare diseases are conditions that affect a limited number of individuals, often presenting with intricate symptoms and restricted treatment options. The rise in rare diseases is attributed to advancements in genetic sequencing and diagnostic technologies, which facilitate earlier and more accurate identification of previously undiagnosed or misclassified conditions. HiFi long-read sequencing helps address rare diseases by enabling highly accurate, comprehensive detection of complex genetic variations frequently overlooked by short-read sequencing, thereby leading to faster and more precise diagnoses. For instance, in July 2023, according to the Department of Health & Social Care, a UK-based government department, it is estimated that more than 7,000 rare diseases exist, with new conditions consistently being discovered as research progresses. Approximately 80% of these rare diseases are known to have a genetic basis. Therefore, the growing incidence of rare diseases is driving the expansion of the HiFi long-read sequencing market.
High-Fidelity Long-Read Sequencing Market Segment Outlook: Which Categories Are Expanding The Fastest?
The high-fidelity long-read sequencing market covered in this report is segmented –
1) By Product Type: Instruments; Consumables; Software
2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies
3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications
4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments
2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes
3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software
High-Fidelity Long-Read Sequencing Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Companies operating within the HiFi long-read sequencing market are concentrating on developing advanced solutions, such as hybrid-capture target enrichment. These efforts aim to boost sequencing accuracy, broaden coverage of intricate genomic regions, and hasten the identification of structural variants for sophisticated research and clinical uses. Hybrid-capture target enrichment refers to a genomic sequencing method that selectively separates specific DNA or RNA regions from a sample using complementary probes. This allows for focused, highly accurate sequencing of target areas while minimizing the sequencing of non-relevant segments. For example, in July 2025, QIAGEN N.V., a biotechnology company based in the Netherlands, released its QIAseq xHYB Long Read Panels, expanding its range of next-generation sequencing (NGS) products. This product utilizes hybrid-capture enrichment to facilitate accurate long-read sequencing of complex genomic areas like repeats and structural variants, overcoming the drawbacks of short-read methods. The panels deliver outstanding uniformity, specificity, and full coverage for applications such as cancer profiling, HLA typing, and haplotype phasing. They come in adaptable fixed or custom formats and support integrated workflows from DNA preparation to bioinformatics analysis. Benefits include improved efficiency and more in-depth insights for precision medicine.
High-Fidelity Long-Read Sequencing Market Key Companies And Competitive Benchmarking
Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.
Access The Complete High-Fidelity Long-Read Sequencing Market Report:
High-Fidelity Long-Read Sequencing Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model